Symbols

XCUR

Exicure·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 3

Ample Liquidity

Significant Net Income Decline

Price Hits New Low

Price Hits 52-week Low

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About XCUR

Exicure, Inc.

An early-stage biotechnology company that developing nucleic acid therapies targeting RNA to address neurological disorders and hair loss disorders

Industry

Pharmaceutical

Established Date

07/09/2015

Listing Date

07/31/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.exicuretx.com

Security Type

Common stock

Office address

2430 N. Halsted St., Chicago, IL 60614

Business

Introduction

Exicure, Inc., was founded on July 9, 2015. The company is a clinical-stage biotechnology company that develops treatments for immuno-oncology, inflammatory diseases and genetic diseases based on its proprietary spherical nucleic acid (SNA) technology.

Company Financials

EPS

XCUR has released its 2025 Q3 earnings. EPS was reported at -0.39, versus the expected 0, missing expectations. The chart below visualizes how XCUR has performed over recent quarters, highlighting trends in earnings surprises.